MAVYRET is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a combination of two antiviral drugs, glecaprevir and pibrentasvir, which work together to target and inhibit the replication of the HCV. MAVYRET is taken orally once daily for a specified duration, depending on the patient's HCV genotype and treatment history. It has been proven to be highly effective in achieving sustained virologic response, which means clearing the HCV from the body, and has a favorable safety profile.
